Show simple item record

dc.contributor.authorCheng, Z.
dc.contributor.authorSurichan, Somchaiya
dc.contributor.authorRuparelia, K. C.
dc.contributor.authorArroo, R. R. J.
dc.contributor.authorBoarder, M. R.
dc.date.accessioned2011-09-06T11:10:35Z
dc.date.available2011-09-06T11:10:35Z
dc.date.issued2011
dc.identifier.citationCheng, Z. (2011) Tangeretin and its metabolite 4 '-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K. British Journal of Pharmacology, 162 (8), pp. 1781-1791en
dc.identifier.issn1476-5381
dc.identifier.urihttp://hdl.handle.net/2086/5198
dc.description.abstractThe mechanisms by which the dietary compound tangeretin has anticancer effects may include acting as a prodrug, forming an antiproliferative product in cancer cells. Here we show that tangeretin also inhibits cell cycle progression in hepatocytes and investigate the role of its primary metabolite 4'-hydroxy-5,6,7,8-tetramethoxyflavone (4'-OH-TMF) in this effect. EXPERIMENTAL APPROACH We used epidermal growth factor (EGF)-stimulated rat hepatocytes, with [(3)H]-thymidine incorporation into DNA as an index of progression to S-phase of the cell cycle, and Western blots for phospho-proteins involved in the cell signalling cascade. KEY RESULTS Incubation of tangeretin with microsomes expressing CYP1A, or with hepatocytes, generated a primary product we identified as 4'-OH-TMF. Low micromolar concentrations of tangeretin or 4'-OH-TMF gave a concentration-dependent inhibition of EGF-stimulated progression to S-phase while having little effect on cell viability. To determine whether time for conversion of tangeretin to an active metabolite would enhance the inhibitory effect we used long pre-incubations; this reduced the inhibitory effect, in parallel with a reduction in the concentration of tangeretin. The EGF-stimulation of hepatocyte cell cycle progression requires signalling through Akt/mTOR/p70S6K kinase cascades. The tangeretin metabolite 4'-OH-TMF selectively inhibited S6K phosphorylation in the absence of significant inhibition of upstream Akt activity, suggesting an effect at the level of mTOR. CONCLUSIONS AND IMPLICATIONS Tangeretin and 4'-OH-TMF both inhibit cell cycle progression in primary hepatocytes. The inhibition of p70S6K phosphorylation by 4'-OH-TMF raises the possibility that inhibition of the mTOR pathway may contribute to the anticancer influence of a flavonoid-rich diet.en
dc.language.isoenen
dc.publisherWileyen
dc.subjectcitrus flavone tangeretinen
dc.subjectcultured rat hepatocytesen
dc.subjectin-vitroen
dc.subjectcarcinoma cellsen
dc.subjectcancer cellsen
dc.subjecthuman breasten
dc.subjectexpressionen
dc.subjectgrowthen
dc.subjectactivationen
dc.subjectAKTen
dc.titleTangeretin and its metabolite 4'-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6Ken
dc.typeArticleen
dc.identifier.doihttp://dx.doi.org/10.1111/j.1476-5381.2010.01185.x
dc.researchgroupChemistry for Health
dc.peerreviewedYesen
dc.researchinstituteLeicester Institute for Pharmaceutical Innovation - From Molecules to Practice (LIPI)en


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record